Clinical Trial Update: Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial [Phase 3]

View source ↗

Summary

This update notes an ongoing Phase 3 trial evaluating minimally invasive surgery after neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Ovarian Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 3 | Status: RECRUITING